|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Mizuho on October 4, 2021. The analyst firm set a price target for 6.00 expecting LPTX to rise to within 12 months (a possible 106.90% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $2.9 last updated Mon Oct 25 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Leap Therapeutics.
Leap Therapeutics’s $Q3 earnings are confirmed for after-market on $November 11, 2021.
There is no upcoming split for Leap Therapeutics.
Leap Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.